Full-Time

Associate I

Quality Control, Microbiology, Environmental Monitoring

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Entry

Marlborough, MA, USA

This position is site-based, requiring full-time presence at Moderna’s site.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • BS in a relevant scientific discipline or 5 years Quality Control experience in a cGMP organization with a focus in Microbiology
  • This position is site-based, requiring you to be at Moderna’s site full-time. This position is not eligible for remote work.
Responsibilities
  • Perform routine environmental monitoring and critical utility sampling activities.
  • Conduct analysis of water samples to include TOC, Conductivity, Bioburden, and Endotoxin.
  • Conduct process gasses testing for Total particulates, Viable Air, Hydrocarbons and Dewpoint.
  • Perform routine testing in support of manufacturing processes to include bioburden, sterility, endotoxin, culture purity and cell stock identity.
  • Prepare and ship contract laboratory testing samples including those intended for microbiological identification.
  • Perform general laboratory support activities including equipment maintenance and housekeeping.
  • May participate in equipment and method qualifications, validations, and method transfers.
  • Perform data entry utilizing good documentation practices.
  • Support initiation/closure of quality system records such as environmental monitoring excursion notifications and deviations.
  • Write/revise standard operating procedures.
  • Additional duties as may be assigned from time to time

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?